The hypothalamus is now known to regulate alcohol intake in addition to its established role in food intake, in part through neuromodulatory neurochemicals termed neuropeptides. Certain orexigenic neuropeptides act in the hypothalamus to promote alcohol drinking, although they affect different aspects of the drinking response. These neuropeptides, which include galanin, the endogenous opioid enkephalin, and orexin/hypocretin, appear to stimulate alcohol intake not only through mechanisms that promote food intake but also by enhancing reward and reinforcement from alcohol. Moreover, these neuropeptides participate in a positive feedback relationship with alcohol, whereby they are upregulated by alcohol intake to promote even further consumption. They contrast with other orexigenic neuropeptides, such as melanin-concentrating hormone and neuropeptide Y, which promote alcohol intake under limited circumstances, are not consistently stimulated by alcohol, and do not enhance reward. They also contrast with neuropeptides that can be anorexigenic, including the endogenous opioid dynorphin, corticotropin-releasing factor, and melanocortins, which act in the hypothalamus to inhibit alcohol drinking as well as reward and therefore counter the ingestive drive promoted by orexigenic neuropeptides. Thus, while multiple hypothalamic neuropeptides may work together to regulate different aspects of the alcohol drinking response, excessive signaling from orexigenic neuropeptides or inadequate signaling from anorexigenic neuropeptides can therefore allow alcohol drinking to become dysregulated.
Introduction
The hypothalamus has long been known to participate in ingestive behavior. Its role in feeding was first established by Hetherington and Ranson (1940) , when they showed that rats became obese after bilateral electrolytic lesions of the medial hypothalamic nuclei. In 1951, Anand and Brobeck then showed that rats after bilateral destruction of the lateral hypothalamus (LH) instead failed to eat and became emaciated, leading these researchers to designate the LH as a "feeding center" (Anand and Brobeck, 1951) . It was not until 1970 that it was suggested, by Marfaing-Jallat, Larue, and Le Magnen (1970) , that the hypothalamus also participated in alcohol drinking. These researchers demonstrated that rats with lesions of the medial hypothalamus exhibit hyperphagia not just toward food but also toward alcohol (Marfaing-Jallat et al., 1970) . Conversely, electrical stimulation of the LH led rats to drink alcohol at intoxicating levels (Wayner et al., 1971) . Alcohol itself is energy dense, containing 7 kcal/g, as compared to the 4 kcal/g of protein and carbohydrate and the 9 kcal/g of fat. For this reason, alcohol can be considered to be a food as well as a drug. It is notable that the hypothalamus, in addition to controlling energy intake, also controls reward from ingestive behavior. Rats work to receive electrical stimulation of the LH ("self-stimulation"), and manipulation of the hypothalamic feeding sites correspondingly affects their rate of self-stimulation (Hoebel and Teitelbaum, 1962) . Thus, the hypothalamic regulation of alcohol intake may be connected to both the calories it provides and the reward it induces.
The discovery of neuropeptides in the brain (de Wied, 1974) has led researchers to consider that these local neuromodulatory neurochemicals may contribute to the ability of the hypothalamus to influence alcohol intake. In fact, many hypothalamic neuropeptides that participate in food intake have also been found to participate in alcohol intake. Much of this work has focused on certain orexigenic neuropeptides traditionally associated with increased food intake, including galanin (GAL), enkephalin (ENK), orexin/hypocretin (OX), melaninconcentrating hormone (MCH), and neuropeptide Y (NPY), which generally are upregulated by alcohol intake and can also promote its intake. In addition, neuropeptides sometimes described as anorexigenic, those that reduce food intake, such as dynorphin (DYN), corticotropinreleasing factor (CRF), and melanocortins (MCs) are often also 
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